PMID: 3753996Mar 1, 1986Paper

Modulation of endothelial cell hemostatic properties by tumor necrosis factor

The Journal of Experimental Medicine
P P Nawroth, D M Stern

Abstract

Tumor necrosis factor/cachectin (TNF) is a mediator of the septic state, which involves diffuse abnormalities of coagulation throughout the vasculature. Since previous studies have shown that endothelial cells can play an active role in coagulation, we wished to determine whether TNF could modulate endothelial cell hemostatic properties. Incubation of purified recombinant TNF with cultured endothelial cells resulted in a time- and dose-dependent acquisition of tissue factor procoagulant activity. Concomitant with enhanced procoagulant activity, TNF also suppressed endothelial cell cofactor activity for the anticoagulant protein C pathway; both thrombin-mediated protein C activation and formation of functional activated protein C-protein S complex on the cell surface were considerably attenuated. Comparable concentrations of TNF (half-maximal affect at approximately 50 pM) and incubation times (half-maximal affect by 4 h after addition to cultures) were required for each of these changes in endothelial cell coagulant properties. This unidirectional shift in cell surface hemostatic properties favoring promotion of clot formation indicates that, in addition to leukocyte procoagulants, endothelium can potentially be instrumental in...Continue Reading

References

Apr 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·D SternW Kisiel
Oct 1, 1985·The Journal of Experimental Medicine·D M SternE A Jaffe
Jul 1, 1984·The Journal of Clinical Investigation·R D Rosenberg, J S Rosenberg
Jun 1, 1981·The Journal of Clinical Investigation·S G Gordon, B A Cross

❮ Previous
Next ❯

Citations

Mar 1, 1997·American Journal of Hematology·K OkajimaK Takatsuki
May 1, 1996·Seminars in Surgical Oncology·T KurokawaH Takagi
Sep 1, 1991·American Journal of Hematology·H A LiebmanJ M Dilorio
Oct 12, 2011·Inflammatory Bowel Diseases·Hideo YoshidaD Neil Granger
Jan 1, 1993·Transplant International : Official Journal of the European Society for Organ Transplantation·K KawanoM Kobayashi
Jan 1, 1987·Virchows Archiv. A, Pathological Anatomy and Histopathology·B Iványi, W Thoenes
Mar 1, 1991·Biulleten' eksperimental'noĭ biologii i meditsiny·Iu V PersidskiĭIu A Barshteĭn
Jan 1, 1992·Virchows Archiv. A, Pathological Anatomy and Histopathology·U SturmM Müller
Apr 15, 1987·Klinische Wochenschrift·R Munker, H P Koeffler
Apr 1, 1989·Cardiovascular Drugs and Therapy·P P Nawroth, D M Stern
Jul 1, 1994·Digestive Diseases and Sciences·P ChamouardR Baumann
Jan 1, 1990·Biotherapy·M Scheringa, R L Marquet
Jul 5, 2003·Journal of Tongji Medical University = Tong Ji Yi Ke Da Xue Xue Bao·M ZhangJ Zhang
Jan 1, 1986·Immunologic Research·B Beutler, A Cerami
Aug 2, 2011·Seminars in Immunopathology·Edward M Conway
Jan 17, 2008·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Wolfgang Korte
Mar 31, 2012·Journal of Molecular Histology·Shaima M AlmasryFawzia A Habib
Aug 9, 1991·Brain Research·V L WongM Fisher
Jul 1, 1989·Cellular Immunology·M R ShalabyT Espevik

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.